The genetics of aging-- implications for pharmacogenomics
Related Experiment Video
Updated: Sep 30, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
1Geriatrics Section, Boston University Medical Center, 88 East Newton Street, F4, Boston, MA 02118, USA. thomas.perls@bmc.org
Abstract:
Lifespan experiments of lower organisms and mammals along with recent studies of centenarians are making inroads into delineating genetic factors that determine the ability to achieve exceptional longevity. These models may be helpful for the discovery of both longevity-enabling genes as well as genes associated with increased propensity to develop specific diseases. Both academic and commercial laboratories are putting substantial resources into discovering such genes in order to better understand the genetic and environmental underpinnings of how some people age more slowly than others and markedly delay or even escape age-associated diseases.
Related Concept Videos
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacogenetics of Drug Metabolism: Overview
